BRCA1/2 mutations

BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma
Ilan Bruchim, Keren Amichay, Dvora Kidron, Zohar Attias, Tal Biron-Shental, Liat Drucker, Eitan Friedman, Haim Werner, Ami Fishman

International Journal of Gynecologic Cancer Oct 2010, 20 (7) 1148-1153; DOI: 10.1111/IGC.0b013e3181ef622d
Fatigue and Quality of Life After Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Hereditary Breast-Ovarian Cancer
Trond M. Michelsen, Anne Dørum, Claes G. Tropé, Sophie D. Fosså, Alv A. Dahl

International Journal of Gynecologic Cancer Jul 2009, 19 (6) 1029-1036; DOI: 10.1111/IGC.0b013e3181a83cd5
Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing
Paul A. Cohen, Cassandra B. Nichols, Lyn Schofield, Steven Van Der Werf, Nicholas Pachter

International Journal of Gynecologic Cancer Jun 2016, 26 (5) 892-897; DOI: 10.1097/IGC.0000000000000689
Added Value of Family History in Counseling About Risk of BRCA1/2 Mutation in Early-Onset Epithelial Ovarian Cancer
Marieke Arts-de Jong, Catharina M. Manders, Nicoline Hoogerbrugge, Marjolijn J.L. Ligtenberg, Leon F. Massuger, Joanne A. de Hullu, Liesbeth Spruijt

International Journal of Gynecologic Cancer Oct 2013, 23 (8) 1406-1410; DOI: 10.1097/IGC.0b013e3182a1cf71

Main menu